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 Congenital hearing loss (HL) is globally the most prevalent 
sensorineural disorder which present in 1 of every 500 newborns 
(Morton  & Nance, 2006). Genetic causes account for at least half of 
the etiology in cases with congenital HL. About 70% of genetic HL 
cases are non-syndromic (NSHL), where no other anomaly exists, 
while the remaining 30% include syndromic forms. So far, over 400 
syndromic HL have been identifi ed and Pendred syndrome (PS), 
an autosomal recessive sensorineural HL associated with enlarged 
vestibular aqueduct (EVA) and thyroid disease, is one of the most 
common examples (Pendred, 1896; Hilgert et  al, 2009). NSHL can 
be inherited as autosomal recessive, dominant, mitochondrial, X- 
and Y-linked (Smith et  al, 2005). Autosomal recessive HL is the 
most common type of HL and is prevalent in the consanguinity 
belt region of the world, including Iran, where consanguineous 
marriage is common (Hilgert et  al, 2009; Smith et  al, 2005). Thus 
far, over 80 autosomal recessive (DFNB) loci have been mapped 
for ARNSHL (Autosomal recessive non-syndromic hearing loss) 
alone which proves extensive genetic heterogeneity of this trait 
(http://www.hereditaryhearingloss.org).  GJB2 mutations comprise 
16 – 18% of ARNSHL in Iran (Chaleshtori et  al, 2007; Najmabadi 
et  al, 2005). Therefore, the rest of the etiology should be due to 
other loci (Tabatabaiefar et  al, 2011). 
 SLC26A4 mutations cause either PS ( OMIM#274600 ) or DFNB4 
HL (OMIM#600791). It is responsible for about 4 – 10% of NSHL 
in different populations (Everett et  al, 1997; Runge-Samuelson  & 
Olivier, 2009). This gene is located at the DFNB4 locus on 7q31 
chromosome (Everett et  al, 1997). Enlarged vestibular aqueduct 
(EVA) and deafness are common features of both of the diseases. In 
addition to these signs, thyroid abnormality is seen in PS (Pendred, 
1896). Among Caucasian patients with non-syndromic EVA, one 
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 Abstract 
 Objective: To determine the prevalence and types of  SLC26A4 mutations and the relevant phenotypes in a series of Iranian deaf patients. 
 Design: A descriptive laboratory study.  Study sample: One hundred and twenty-one families including 60 unrelated patients and 61 
unrelated multiplex families with autosomal recessive deafness were included. In the 61 multiplex families, linkage was conducted 
for short tandem repeats (STRs) of the DFNB4. Selected individuals from the linked families and all of the 60 deaf individuals were 
subjected to sequencing of  SLC26A4 .  Results: Seven out of the 61 (11.5%) families were linked to the locus which upon further inquiry 
led to identifi cation of eight different mutations. Also, fi ve out of the 60 (8.3%) patients were positive for the mutations. The  SLC26A4 
mutations clarifi ed in 9.1% (12 families) of total investigated alleles included: c.2106delG, c.65-66insT, c.881-882delAC, c.863-864insT, 
c.1226G  A, c.1238A   G, c.1334T   G, c.1790T   C, c.1489G  A, c.919-2A   G (IVS7-2A   G), c.1412delT, and c.1197delT. Six out 
of 12 (50%) families with mutations were confi rmed to be Pendred syndrome (PS).  Conclusions: The results probably suggest a high 
prevalence and specifi city of  SLC26A4 mutations among Iranian deaf patients. Molecular study of SLC26A4 may lead to elucidation of 
the population-specifi c mutation profi le which is of importance in diagnostics of deafness. 
 Key Words:  Deafness ;  genetic linkage ;  SLC26A4 ;  mutation screening ;  enlarged vestibular aqueduct ; 
 goiter ;  Iran 
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2    N. Yazdanpanahi et al.
third of patients have been shown to carry two  SLC26A4 mutations, 
one third have one mutation and the rest have zero mutant allele 
(Pryor et  al, 2005; Albert et  al, 2006; Coyle et  al, 1998). 
 The cost and inaccessibility of temporal bone study methods, 
phenocopy, and variability of goiter phenotype make clinical diag-
nosis of  SLC26A4 deafness diffi cult in many populations. Instead, 
molecular screening methods are a more accurate and proper strategy 
than clinical testing (Masmoudi et  al, 2000 ; Napiontek et  al, 2004; 
Fugazzola et  al, 2007). 
 Different investigations have suggested that  SLC26A4 mutations 
are one of the most frequent causes of genetic HL in the world popu-
lations, including Iranians (Park et  al, 2003; Kahrizi et  al, 2009). 
Knowledge about ethnic and population differences in  SLC26A4 
mutation prevalence can improve genetic strategies in diagnosis of 
the disease. 
 In many Iranian deaf patients, genetic cause of deafness remains 
undetectable. Up to now, most studies about the genetics of deafness 
in Iran have been performed on  GJB2 . Based on previous works 
(Kahrizi et  al, 2009; Babanejad et  al, 2012), we launched the current 
study in a cohort of Iranian HL families, with no  GJB2 mutations, to 
investigate  SLC26A4 mutations using molecular tools. 
 Materials and Methods 
 Sampling and DNA extraction 
 This study was approved by the institutional review board of 
Shahrekord University of Medical Sciences. Altogether 121 fami-
lies including 60 unrelated patients (I1-I60), each of which from a 
multiplex family, and 61 unrelated multiplex families (IR1-61) were 
included in this study. All families had positive history of HL and 
were of Persian ethnicity. Also, for pathagenicity investigation 100 
ethnically matched hearing controls were recruited. 
 A written informed consent had been provided for all the patients 
in our previous study (Chaleshtori et  al, 2007). Pedigrees were drawn 
based on the fi lled-out questionnaire and interview with the family 
members. 
 All cases were negative for  GJB2 mutations in our previous 
study (Chaleshtori et  al, 2007) and pedigrees suggested autosomal 
recessive mode of inheritance. There were at least two affected HL 
patients in pedigrees of all 61 families and 60 patients. At least one 
consanguinity loop was also detected in 109 of these pedigrees while 
for the rest of the families inbreeding was most likely the case. 
 For all cases, pure-tone audiometric test for air and bone conduc-
tion at frequencies 250 to 8000 Hz was performed to clarify HL 
severity as follows: mild (21 – 40 dB), moderate (41 – 70 dB), severe 
(71 – 95 dB) and profound (   95 dB). For families with mutation, 
temporal bone CT-scan was conducted using Somatom Sensation 
Emotion 16 - Slice Confi guration (Siemens Medical Solutions, Erlangen, 
Germany) to clarify the vestibular aqueduct situation. EVA was 
considered when the diameter at the midway between the common 
crus and the external aperture was equal to or more than 1.5 mm 
(Berrettini et  al, 2005). 
 For assessing thyroid phenotype, T3, T4, and TSH hormones 
were measured using a chemiluminescent immunoassay (Berthold 
Technology-CSA, Germany) and ultrasonography was performed 
with a Sonoline G50  ™  ultrasound system (Siemens Medical Solutions, 
Erlangen, Germany). Results were interpreted based on sex and age. 
 Clinical phenotype of patients was investigated using temporal 
bone CT-scan, hormone assay and ultrasonography for most or all 
of HL family members. However, for known mutations, these tests 
were performed only for one patient of each family. 
 Genomic DNA for all available members of the families, patients 
and normal controls was extracted from 500  μ l of peripheral blood 
using a standard phenole-chloroform method (Grimberg et  al, 1989). 
 SLINK and STR selection 
 SLINK was calculated by the FastSlink (version 2.51) option of 
EasyLinkage (version 5.05) to evaluate power of the 61 pedigrees 
for linkage strategy (Lindner  & Hoffmann, 2005). The families were 
screened by at least three informative STR markers before ruling out 
the linkage. In case evidence of linkage was observed, more addi-
tional markers were run to confi rm the result. Altogether fi ve STR 
markers for DFNB4 locus including D7S2459, D7S496, D7S2456, 
D7S2420, and D7S2425 were used in this study. They were selected 
based on NCBI MapViewer and UniSTS data. 
 STR genotyping and linkage analysis 
 Touch-down PCR was used for amplifi cation of all STR markers. 
STR genotypes were assessed on 14% Polyacrylamide gel using 
transilluminator (Vilber Lourmat Deutschland GmbH, Germany). 
A subset of the results was confi rmed by fragment analysis on an 
ABI 3730XL automated sequencer (Applied Biosystems). 
 Calculation of LOD score was combined with haplotype analysis 
for confi rmation or exclusion of linkage. SuperLink (version 1.6) 
and SimWalk (version 2.91) options of EasyLinkage (version 5.05) 
were applied to obtain two and multipoint LOD score, respectively 
(Lindner  & Hoffmann, 2005; Fishelson  & Geiger, 2004). For LOD 
calculation, complete penetrance, autosomal recessive inheritance, 
disease-allele frequency of 0.001, no phenocopy, and equal recom-
bination frequencies in both male and female were considered. 
Haplotypes were visualized by Haplopainter software (version 
029.5) (Thiele  & Nurnberg, 2005). 
 Mutation screening of SLC26A4 
 In seven linked families and all the 60 patients, sequencing of the 
 SLC26A4 gene was done to identify mutations. Twenty-one exons, 
exon-intron boundaries, and the promoter of the  SLC26A4 gene were 
amplifi ed by standard PCR programs (assay conditions are available 
upon request).  SLC26A4 primers were designed using Oligo (version 
6.7.1.0 National Biosciences Inc.) (Yazdanpanahi et  al, 2012). 
 The PCR products were sequenced using an ABI 3730XL auto-
mated sequencer (Applied Biosystems). The resultant sequences 
were compared with  SLC26A4 reference sequence (NM_000441.1) 
using chromas (Version 2.33). 
 Pathogenicity investigation for variants c.2106delG, c.65-66insT, 
c.881-882delAC, c.863-864insT and c.1412delT was checked in 
our previous studies (Tabatabaiefar et  al, 2010; Yazdanpanahi et  al, 
2012) and for the variant with unknown pathogenicity, c.1238A   G 
 Abbreviations 
 ARNSH  Autosomal recessive non-syndromic hearing loss 
 EVA  Enlarged vestibular aqueduct 
 HL  Hearing loss 
 NHS  Non-syndromic hearing loss  
 PS  Pendred syndrome  
 STR  Short tandem repeat 
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 SLC26A4 mutations in Iranian patients with  deafness     3
(p.Gln413Arg) found in the current study. Study of pathogenicity 
was based on the nature of variants, evolutionary conservation of 
substituted amino acid, co-segregation in family members, and 
absence of variants in at least 100 hearing ethnically matched con-
trols. PCR-RFLP-Polyacrylamide gel system were developed for 
each allelic variant (assay conditions are available upon request). 
 Results 
 Family data, SLINK and linkage analysis results 
 Altogether, 61 multiplex families (IR1-61) with 355 patients and 
also 60 patients, with positive history for deafness in their pedigrees 
(I1-I60), with congenital HL, and of Persian ethnicity were included 
in this study. SLINK average of the 61 families studied by linkage 
analysis was 3.33. There was at least one consanguinity loop within 
any of the pedigrees in 49 out of 61 (80%) families and all of the 
60 HL patients. The average number of consanguinity loop within 
families was two. 
 Seven out of the 61 (11.5%) families were linked to DFNB4. 
SLINK, two-point and multi-point LOD score values for the seven 
linked families are shown in supplementary results, Supplementary 
Table 1 available online at http://informahealthcare.com/doi/abs/
10.3109/14992027.2014.944276. The pedigree of one of the families 
(IR35) including the haplotypes is shown in Figure 1. 
 SLC26A4 mutation screening results 
 A total of 12 different  SLC26A4 mutations including c.2106delG, 
c.65-66insT, c.881-882delAC, c.863-864insT, c.1226G  A (p.Arg
409His), c.1238A   G (p.Gln413Arg), c.1334T   G (p.Leu445Trp), 
c.1790T   C (p.Leu597Ser), c.1489G  A (p.Gly497Cys), c.919-2A   G 
(IVS7-2A   G), c.1412delT, and c.1197delT were detected in 22 out 
of the 242 (9.1%) total studied alleles (Figure 2). In two families, 
only one heterozygous mutation was detected, two families were 
compound heterozygote and the remaining eight families were 
homozygote (See below). Five mutations (c.2106delG, c.65-66insT, 
c.881-882delAC, c.863-864insT, and c.1412delT), seen in four linked 
families, were reported as novel in our previous studies (Tabatabaie-
far et  al, 2010; Yazdanpanahi et  al, 2012, 2013). The c.863-864-
insT and c.881-882delAC mutations were respectively identifi ed in 
homozygous state in patients of the right and left sides of a large ped-
igree from Fars province, while was also found to be in compound 
heterozygous state in one patient from the pedigree (Yazdanpanahi 
et  al, 2013). Three known mutations: c.1489G  A (p.Gly497Cys), 
c.919-2A   G, and c.1197delT were identifi ed in three more linked 
families. Interestingly, c.1489G  A (p.Gly497Cys) and c.1197delT 
were found as compound heterozygous in a subset of patients from 
family IR35 (Figure 1). The four remaining mutations were found 
in fi ve out of the 60 (8.3%) patients: c.1790T   C (p.Leu597Ser) 
was revealed in two different patients heterozygously. All of other 
mutations were homozygous (Table 1). 
 The results of our previously works suggested the pathogenicity 
role of the variants c.2106delG, c.65-66insT, c.881-882delAC, c.863-
864insT, and c.1412delT (Tabatabaiefar et  al, 2010; Yazdanpanahi 
et  al, 2012, 2013). In the present study c.1238A   G (p.Gln413Arg) 
variant (with unkown pathogenicity) showed co-segregation with 
deafness in the related family members (supplementary results, 
Supplementary Figures 1, a, b, and 2 available online at http://
informahealthcare.com/doi/abs/10.3109/14992027.2014.944276). 
The mentioned variant is a missense mutation resulting in 
 Figure 1. Haplotypes of the family IR35. Three different haplotype combinations were shown to be segregating with the disease. Maximum 
two-point and Multi-point LOD scores were 3.4 (for D7S2420) and 4.5 (for D7S2459), respectively. The order of the markers is based 
on LDB map. In one of the parents of individual 1 (V-4 from the left side pedigree) a cross-over event has occurred resulting in a novel 
haplotype distal to D7S2459 in him (not shown for him due to unavailability of the sample) as well as his progeny. Interestingly, all of 
the patients in the left side pedigree with either the original homozygous haplotype (3-6-2-2-4) or the combination of the original and the 
novel haplotypes (3-6-2-2-4/3-6-2-3-3) showed homozygous c.1197delT mutation. Two patients from the right side pedigree showed the 
combination of the original and a third haplotype (3-6-2-2-4/3-3-2-2-2). Both are compound heterozygous for c.1197delT/ c.1489G  A 
(p.Gly497Cys) which could serve as evidence that  SLC26A4 mutations are a frequent cause of hereditary deafness in the region (Khuzestan 
province, southwest Iran). 
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the Glutamine to Arginine substitution (p.Gln413Arg). Glutamine is 
an uncharged polar amino acid but Arginine is a positively charged 
polar amino acid. Therefore, it is possible for the substitution to 
exert an effect on the structure, charge and function of the pro-
tein. Moreover, running Consurf server (http://consurf.tau.ac.il) 
revealed a high conservation score (8) for Glutamine at position 
413 (Figure 3). This is evidence of high conservation degree of 
Glutamine 413 among orthologs. 
 Analysis of control individuals for c.1238A   G (p.Gln413
Arg) revealed that one out of 143 individuals had this mutation 
heterozygously. 
 Clinical results 
 Clinical characterizations of families with  SLC26A4 mutations have 
been shown in Table 1. All the patients with mutation had severe to 
profound deafness, except one patient (age: 8 years) of IR3 family 
with moderate HL (Table 1). EVA was seen in all of the 10 families 
tested; no data were available for the two remaining families. Six out 
of the 12 (50%) families with mutations showed goiter. Phenotype 
of thyroid was sometimes variable even among the patients of the 
same family. Hypothyroidism was only detected in a 35-year-old 
patient of IR2 family. 
 Discussion 
 SLC26A4 has been reported as the second leading cause of autosomal 
recessive HL in many populations. The frequency and spectrum of 
 SLC26A4 mutations are different among various deaf populations 
(Table 2). So far, only little has been known about  SLC26A4 muta-
tions in the Iranian population. Here, we could detect mutations in   Ta
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 Figure 2. Location of  SLC26A4 mutations at the gene (a) and protein 
(b) levels. (b) A: c.65-66insT, B: c.863-864insT, C: c.881-882delAC, 
D: c.1197delT, E: c.1226G  A (p.Arg409His), F: c.1238A   G 
(Gln413Arg), G: c.1334T   G (p.Leu445Trp), H: c.1412delT, I: 
c.1489G  A (p.Gly497Cys), J: c.1790T   C (p.Leu597Ser), K: 
c.2106delG. (The mutation c.919-2A   G is intronic and does not 
change amino acid at the protein level). 
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 Figure 3. Result of Gln (Q)413 conservation investigation using consurf database. Gln (Q)413 amino acid is shown with arrow. 
 Table 2.  SLC26A4 mutations in different populations. 
 Population 
 No. of studied families 
(total alleles)  No. of mutated alleles (%)  The most frequent mutation (%)  Protein effect  Reference 
US 255 (510) 35 (35/510    6.9) c.1003T   C (5/35    14.3) p.Phe335Leu Dai et  al, 2009
Spanish 67 (134) 36 (36/134    26.9) c.1540C  A (6/36    17) p.Gln514Lys Pera et  al, 2008b
Taiwanese 101 (202) 150 (150/202    74.2) c.919-2A   G (115/150    76.7) – Wu et  al, 2010
Chinese 302 (604) 131 (131/604    21.7) c.919-2A   G (100/131    76.3) – Dai et  al, 2009
Pakistanis 775 (1550) 112 (112/1550    7.2) c.716T  A (34/112    30.3) p.Val239Val Anwar et  al, 2009
Turkish 293 (586) 6 (6/586    1) – – Tekin et  al, 2003
Iranian 80 (160) 16 (16/160    10) – – Kahrizi et  al, 2009
144 (288) 14 (14/288    4.8) – – Babanejad et  al, 2012
121 (242) 22 (22/242    9.1) – – This study
9.1% of total investigated alleles. The frequency of  SLC26A4 muta-
tions among the Iranian HL patients has been reported to be 10% 
and 4.8% in two previous studies (Kahrizi et  al, 2009; Babanejad 
et  al, 2012). Thus, the results of our research with a relatively higher 
sample size, confi rm the fi nding obtained by Kahrizi and colleagues 
(Kahrizi et  al, 2009). The discrepancy between results obtained with 
our investigation and that performed by Babanejd and colleagues 
(Babanejad et  al, 2012) might be due to ethnicity differences. 
 Notably, the result of the present study might be an over-
estimation since they include heterozygotes with a second uniden-
tifi ed mutation . Detection of EVA in these heterozygotes patients 
may be evidence of the presence of the second unidentifi ed trans 
mutation. The missing cause is most likely a non-coding mutation 
or a large deletion in the coding region. Digenic mutations are also 
among the less likely alternative causes. Recently, digenic inheri-
tance has been pinpointed in  KCNJ10/SLC26A4 (Yang et  al, 2009) 
as well as FOX11/SLC26A4 (Yang et  al, 2007). Thus, these two genes 
could be interesting targets for further investigations. 
 c.2106delG, c.65-66insT, c.881-882delAC, c.863-864insT and 
c.1412delT are most probably pathogenic (Tabatabaiefar et  al, 2010; 
Yazdanpanahi et  al, 2012, 2013). The pathogenic role of mutation 
c.1238A   C causing the replacement of Glutamine in position 413 
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by Proline (p.Gln413Pro) has been formerly reported (Pera et  al, 
2008a). Pathogenicity study of c.1238A   G (p.Gln413Arg) in the 
present investigation suggests this variant is probably pathogenic. 
Five out of 12 (41.7%) mutations (c.2106delG, c.65-66insT, 
c.881-882delAC, c.863-864insT and c.1412delT) were reported in 
our previous studies for the fi rst time (Tabatabaiefar et  al, 2010; 
Yazdanpanahi et  al, 2012, 2013). They may be unique to the 
Iranian population which should be further investigated. Exon 10 
had the most number of mutations. We could detect two mutations 
(c.881-882delAC, c.863-864insT) in a single family, a proof for the 
high frequency of  SLC26A4 mutations among deaf families in Iran. 
Unlike  GJB2 , the  SLC26A4 gene has a bigger role in Asian than 
Caucasian populations (Park et  al, 2003; Anwar et  al, 2009; Dai 
et  al, 2009) and p.L236P, p.T416P, p.E384G and IVS8    1G  A 
are the most frequent mutations of this gene in many populations 
(Coyle et  al, 1998; Van Hauwe et  al, 1998) but c.919-2A   G 
(IVS7-2A   G) and H732R mutations are more prevalent in East 
Asia (Park et  al, 2003); c.919-2A   G (IVS7-2A   G) has also 
been found in one of the families of our study. Four mutations 
(p.Arg409His, p.Leu597Ser, p.Leu445Trp and c.1197delT) were 
identifi ed both in this study and the previous investigation in the 
Iranian population (Kahrizi et  al, 2009) and may be among the 
prevalent  SLC26A4 mutations in Iran. These results suggest a high 
allelic heterogenity yet possible unique spectrum of  SLC26A4 
mutations among Iranian patients. It might also be reasonable and 
cost-effective to initiate screening of  SLC26A4 with the search for 
these probably prevalent mutations. 
 In the current study six out of the 12 (50%) families with  SLC26A4 
mutations had PS syndrome. In the previous studies in Iran, all of 
families with  SLC26A4 mutations were diagnosed with PS (Kahrizi 
et  al, 2009; Babanejad et  al, 2012). These results suggest that PS 
is probably a prevalent syndromic form of HL which has to be 
considered in molecular diagnostics in the Iranian deaf patients. 
Variable thyroid phenotype observed in this study among the 
patients with  SLC26A4 mutations has been reported by some 
investigators (Masmoudi et  al, 2000; Napiontek et  al, 2004; 
Fugazzola et  al, 2007). This might be due to environmental and 
epigenetic factors as well as modifi er genes. EVA was a constant 
feature among all the tested patients in this study. 
 Conclusion 
 From data presented here, it is apparent that  SLC26A4 mutations 
are likely to be the second most common cause of deafness after 
 GJB2 in Iran . Therefore it should be noted in molecular diagnosis 
of HL, especially when EVA and or goiter are observed. 
 In summary, in the current study, we have addressed the frequency 
and spectrum of  SLC26A4 among Iranian subjects with hereditary 
HL. Our results confi rm the role of the gene in pathogenesis of HL in 
Iran and might provide an insight into some prevalent mutations that 
are worth being prioritized in molecular diagnostics of HL in Iran. In 
view of the heterogeneity of the Iranian population, which consists 
of ethnicities of Persian, Azeri, Kurdish, Gilaki, Arab, Baloochi, Lur, 
etc., it would be interesting to study ethnic groups separately to bet-
ter clarify the issue. 
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